Amarin Corp Plcuk (AMRN) Other financing activities (2011 - 2020)

Amarin Corp Plcuk (AMRN) reported Other financing activities of $238000.0 for Q4 2020, up 750.0% quarter-over-quarter from $28000.0 in Q3 2020.

Amarin Corp Plcuk (AMRN) Other financing activities (2011 - 2020) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 7 years of Other financing activities data on file, last reported at $238000.0 in Q4 2020.

  • Other financing activities for Q4 2020 came in at $238000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $266000.0 (changed N/A YoY), and the FY2020 annual result was $504000.0, changed N/A from the prior year.
  • Other financing activities grew to $238000.0 in Q4 2020 per AMRN's latest filing, from $28000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $1.2 million in Q1 2017 and troughed at $28000.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 238,000.00
Dec 31, 2020 238,000.00
Sep 30, 2020 28,000.00
Sep 30, 2020 28,000.00
Mar 31, 2017 1.21 Mn
Mar 31, 2017 1.21 Mn
Dec 31, 2015 1.43 Mn
Dec 31, 2015 1.43 Mn
Sep 30, 2015 -66,000.00
Sep 30, 2015 -66,000.00
Jun 30, 2015 -89,000.00
Jun 30, 2015 -89,000.00
Mar 31, 2015 -552,000.00
Mar 31, 2015 -552,000.00
Sep 30, 2014 55,000.00
Sep 30, 2014 55,000.00
Jun 30, 2014 2.43 Mn
Jun 30, 2014 2.43 Mn
Mar 31, 2014 -1,000.00
Mar 31, 2014 -1,000.00